BIZILY SCOTT (Chief Legal Officer) sold 53.2% of their position (9.81K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $117.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001920738-26-000002
Officer· Chief Legal Officer
Since Mar 2022
-9.81K
Net shares
Net seller
$117.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.81K acquired · 19.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.81K
Price / share
$4.14
Trade value
$40.61K
% of position
113.8%
6/23/2026
8.62K→18.43K
Common Stock
Direct
Shares
−9.81K
Price / share
$12.00
Trade value
$117.72K
% of position
53.2%
6/23/2026
18.43K→8.62K
Total
Net shares
+0.00
Net value
-$77.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2026 | M · Option Exercise | +9.81K | $4.14 | $40.61K | 113.8% | 8.62K | 18.43K |
| Common Stock Direct | 6/23/2026 | S · Sale | −9.81K | $12.00 | $117.72K | 53.2% | 18.43K | 8.62K |
| Total | +0.00 | -$77.11K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.81K shares
Shares
−9.81K
Strike price
4.14
Held after
63.78K
Exercisable
—
6/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock9.81K shares | 6/23/2026 | M · Option Exercise | −9.81K | 4.14 | — | 63.78K |